Med Tech Acquisition Corp MTACW
Institutional shares held
66,666
0
calls
0
puts
Total value of holdings
$14K
$0
calls
$0
puts
Market Cap
N/A
Institutional ownership
N/A
# of Institutions
1
We take great care to ensure that the data presented and summarized in this overview for MedTech Acquisition Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MTACW
View allLatest Institutional Activity in MTACW
Top Purchases
Top Sells
About MTACW
Insider Transactions at MTACW
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2024
|
Mats Wahlstrom |
BUY
Grant, award, or other acquisition
|
Direct |
25,188
+38.1%
|
$75,564
$3.97 P/Share
|
|
Dec 17
2024
|
Equity Ab Frankenius |
BUY
Open market or private purchase
|
Direct |
62,972
+1.0%
|
$188,916
$3.97 P/Share
|
|
Dec 10
2024
|
Arjun Jj Desai |
SELL
Open market or private sale
|
Direct |
30,000
-10.83%
|
$90,000
$3.69 P/Share
|
|
Nov 22
2024
|
Mats Wahlstrom |
BUY
Open market or private purchase
|
Direct |
5,000
+24.12%
|
$20,000
$4.55 P/Share
|
|
Nov 21
2024
|
Mats Wahlstrom |
BUY
Open market or private purchase
|
Direct |
8,687
+44.75%
|
$34,748
$4.44 P/Share
|
|
Nov 20
2024
|
Mats Wahlstrom |
BUY
Open market or private purchase
|
Direct |
2,040
+50.0%
|
$8,160
$4.16 P/Share
|
|
Nov 14
2024
|
Richard Marshak SR.VP, CORP. DEV. & STRATEGY |
BUY
Grant, award, or other acquisition
|
Direct |
6,875
+16.77%
|
-
|
|
Oct 05
2024
|
Bryan F. Cox CHIEF SCIENTIFIC & MANUFACT. |
SELL
Open market or private sale
|
Direct |
314
-0.36%
|
$1,256
$4.44 P/Share
|
|
Sep 13
2024
|
Mary T Szela CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct |
7,295
+0.94%
|
$29,180
$4.92 P/Share
|
|
Sep 12
2024
|
Mary T Szela CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct |
7,520
+1.95%
|
$37,600
$5.2 P/Share
|
|
Sep 10
2024
|
Mary T Szela CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct |
5,000
+1.33%
|
$20,000
$4.97 P/Share
|
|
Aug 28
2024
|
George Kelly Martin |
SELL
Open market or private sale
|
Indirect |
9
-0.0%
|
$45
$5.5 P/Share
|
|
Jul 01
2024
|
Arjun Jj Desai |
BUY
Grant, award, or other acquisition
|
Direct |
74,000
+21.08%
|
-
|
|
Feb 13
2024
|
Mary T Szela CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
84,899
+18.88%
|
-
|
|
Feb 12
2024
|
Bryan F. Cox CHIEF SCIENTIFIC & MANUFACT. |
BUY
Grant, award, or other acquisition
|
Direct |
14,752
+14.54%
|
-
|
|
Feb 12
2024
|
Richard Marshak SR.VP, CORP. DEV. & STRATEGY |
BUY
Grant, award, or other acquisition
|
Direct |
14,752
+35.12%
|
-
|
|
Feb 12
2024
|
Jennifer Stevens CHIEF REGULATORY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,752
+31.03%
|
-
|
|
Feb 12
2024
|
Jodi Devlin PRESIDENT, COMMERC. OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+50.0%
|
-
|
|
Feb 12
2024
|
Sean Murphy CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
34,144
+40.2%
|
-
|
|
Feb 12
2024
|
Steven C Katz CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
34,144
+33.24%
|
-
|
Last 12 Months Summary
Buy / Acquisition
420K
Shares
From
12
Insiders
| Grant, award, or other acquisition | 321K shares |
|---|---|
| Open market or private purchase | 98.5K shares |
Sell / Disposition
30.3K
Shares
From
3
Insiders
| Open market or private sale | 30.3K shares |
|---|